Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.

Pediatric dermatology - 1 Sept 2021

Zhu Huiying, Song Pingping, Du Donghong, Tian Hongqing

Abstract excerpt

We report a case of a 3-year-old girl with generalized pustular psoriasis (GPP) and a compound heterozygous mutation within the IL36 receptor antagonist (IL36RN) gene at c.28C>T and c.115+6T>C, who was successfully treated using secukinumab monotherapy. The first dose of secukinumab (150 mg) was administered subcutaneously, followed by 75 mg of secukinumab subcutaneously once weekly for 4 weeks and then 75 mg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukins

Share to Mutation

Share to Psoriasis

Share to Treatment Outcome

Source

Identifiers

PMID: 34515373
DOI: 10.1111/pde.14795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.PMID 34515373Read ↗

Excellent response to secukinumab in an infant with severe generalized pustular psoriasis.Semantic proximity Read ↗

Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations.Semantic proximity Read ↗

An update on genetic basis of generalized pustular psoriasis (Review).Semantic proximity Read ↗

Spesolimab for generalized pustular psoriasis: a prospective study with a 6-month follow-up.Semantic proximity Read ↗

Clinical advances in biological therapy for generalized pustular psoriasis: a review.Semantic proximity Read ↗

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.Semantic proximity Read ↗

Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics.Semantic proximity Read ↗

Pathophysiology of generalized pustular psoriasis.Semantic proximity Read ↗

Generalized pustular psoriasis-like drug eruption manifested by systemic glucocorticosteroid in a patient without IL36RN mutation or an immunological disorder.Semantic proximity Read ↗

Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.Semantic proximity Read ↗

Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.Semantic proximity Read ↗

Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.